Hangzhou Tigermed Consulting Co (HKSE:03347) Debt-to-Revenue : 0.61 (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Hangzhou Tigermed Consulting Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was HK$3,645 Mil. Hangzhou Tigermed Consulting Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was HK$926 Mil. Hangzhou Tigermed Consulting Co's annualized Revenue for the quarter that ended in Sep. 2024 was HK$7,528 Mil. Hangzhou Tigermed Consulting Co's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.61.

Hangzhou Tigermed Consulting Co Debt-to-Revenue Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Debt-to-Revenue Chart

Hangzhou Tigermed Consulting Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

Get a 7-Day Free Trial

0.39

0.12

0.23

0.40

0.46

Hangzhou Tigermed Consulting Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Revenue	Get a 7-Day Free Trial															0.48	0.49	0.55	0.61	0.61

Competitive Comparison of Hangzhou Tigermed Consulting Co's Debt-to-Revenue

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou Tigermed Consulting Co's Debt-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's Debt-to-Revenue falls into.

Hangzhou Tigermed Consulting Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Hangzhou Tigermed Consulting Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(2770.858	+	937.732)	/	8076.506
	=	0.46

Hangzhou Tigermed Consulting Co's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(3644.595	+	926.374)	/	7528.384
	=	0.61

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.

Hangzhou Tigermed Consulting Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Tigermed Consulting Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

5HZ1:Germany 300347:China

Address

Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053

Website

https://www.tigermed.net

Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Executives

Sands Capital Management, Llc	2101 Beneficial owner
Sands Capital Management, Lp	2201 Interest of corporation controlled by you
Sands Family Trust, Llc	2201 Interest of corporation controlled by you
Sands Frank Melville Jr.	2201 Interest of corporation controlled by you
Yi Fang Da Ji Jin Guan Li You Xian Gong Si	2102 Investment manager
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
F-j Sands Family I, Llc	2201 Interest of corporation controlled by you
2017 Eagle Holdings Llc	2201 Interest of corporation controlled by you
Citigroup Inc.	2201 Interest of corporation controlled by you
Ubs Group Ag	2201 Interest of corporation controlled by you
Blackrock, Inc.	2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co.	2502 Approved lending agent
Ninety One Plc/ Ninety One Ltd	2102 Investment manager
Ninety One Uk Limited	2102 Investment manager
Baillie Gifford & Co	2102 Investment manager

Hangzhou Tigermed Consulting Co Headlines

No Headlines